What is NDC 70518-4207?

70518-4207 is the product NDC for Adenosine, Adenosine 3 mg/mL injection, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Adenosine?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Adenosine NDC 70518-4207 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4207Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4207Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4207-0	7051842070070518420700	10 VIAL in 1 CARTON (70518-4207-0) / 2 mL in 1 VIAL (70518-4207-1)Marketed from Oct 10, 2024
70518-4207-2	7051842070270518420702	10 VIAL in 1 CARTON (70518-4207-2) / 4 mL in 1 VIAL (70518-4207-3)Marketed from Dec 6, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adenosine
Generic name (nonproprietary): adenosine
Active ingredients: Adenosine — 3 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206778
Marketing start: Oct 10, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Adenosine Receptor Agonists (Mechanism)
Identifiers: Product ID 70518-4207_5a58afce-c732-ac5b-e063-6294a90a2ceeSPL ID 5a58afce-c732-ac5b-e063-6294a90a2ceeSPL set ID 9508caf5-0e3a-4d32-909d-bff7ea40ec30RxCUI 1654169UNII K72T3FS567
Pharmacologic class: Adenosine Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470518420700 followed by a unit qualifier and the quantity

Package 70518-4207-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2026.

Indications (excerpt from the label)

Indications and Usage Intravenous adenosine injection is indicated for the following. Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration. It is important to be sure the adenosine injection solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION ). Adenosine Injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or at…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-4207

What is NDC 70518-4207?: 70518-4207 is the product NDC for Adenosine, Adenosine 3 mg/mL injection, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Adenosine.
What is the active ingredient?: Adenosine.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Adenosine?: 28 other product NDCs are listed under this name. See all Adenosine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Adenosine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-207	71288-0207-21
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-208	71288-0208-30
Adenosineadenosine injection, solution	Adenosine 3 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9993	00404-9993-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1632	51662-1632-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1631	51662-1631-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Sagent Pharmaceuticals	25021-318	25021-0318-0225021-0318-04
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7335	71872-7335-01
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-318	84549-0318-02
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	NorthStar Rx LLC	16714-556	16714-0556-01
Adenosine	Adenosine 3 mg/mL	Injection, SolutionIntravenous	NorthStar Rx LLC	16714-997	16714-0997-01

All 29 Adenosine NDCs

Other NDCs under ANDA 206778

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206778
Product	Strength	Form · route	Labeler	Product NDC
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Sagent Pharmaceuticals	25021-318
Adenosine	Adenosine 3 mg/mL	SolutionIntravenous	Gland Pharma Limited	68083-156
Adenosine	Adenosine 3 mg/mL	SolutionIntravenous	Gland Pharma Limited	68083-157
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7335
Adenosine	Adenosine 3 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-318